Concepedia
Statistics
Publications
37
Citations
3.8K
H-Index
25
Active since
2007
Affiliations
University of Colorado Denver(Current)
University of Colorado Anschutz Medical Campus
Colorado School of Public Health
Center for Human Genetics
Duke University
Diana Abbott is an author at University of Colorado Denver specializing in medicine, oncology, and hematologic malignancy therapy.
Publications per year
2007–2024
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
Daniel A. Pollyea, Brett M. Stevens, Courtney L. Jones et al. · Nature Medicine · 2018 · 797 citations · Full text
Medicine, Oncology, Pharmacology +12
Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia
Shanshan Pei, Daniel A. Pollyea, Annika Gustafson et al. · Cancer Discovery · 2020 · 552 citations
Medicine, Oncology, Pharmacology +13
Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells
Brett M. Stevens, Courtney L. Jones, Daniel A. Pollyea et al. · Nature Cancer · 2020 · 305 citations · Full text
Life Sciences, Hematology, Oncology +14
PD-1 blockade for relapsed lymphoma post–allogeneic hematopoietic cell transplant: high response rate but frequent GVHD
Bradley M. Haverkos, Diana Abbott, Mehdi Hamadani et al. · Blood · 2017 · 242 citations · Full text
Medicine, Hematology, Oncology +17
Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells
Courtney L. Jones, Brett M. Stevens, Daniel A. Pollyea et al. · Cell stem cell · 2020 · 229 citations · Full text
Medicine, Cancer Biology, Oncology +14
1–5 of 37